Abrdn, a Uk-Based Investment Management Company
ABRDN stands for “The Alternative Investment Research and Derivatives Network”, the only investment management company in the UK that offers a full suite of research, trading and execution services including equity, fixed income, forex, derivatives, commodities. Our services are provided by highly skilled professional traders who have traveled extensively to understand how different markets operate around the world.
We offer our clients personalized service with an experienced team available to them 24 hours a day 7 days a week. Not many firms can claim this level of dedication. We believe it is important for you to know that at ABRDN you are dealing with real people in real time who will work with you to assess your needs and then tailor solutions specifically for your requirements. We will help you find the best products and services to meet your portfolio construction and risk management objectives.
ABRDN works hard to offer the most innovative solutions that allow our clients to implement the best performance solutions in the financial markets. We know that success is made up of many factors including finding the right tools for a particular trading style, which is why we work hard to find creative solutions for our clients.
ABRDN’s expertise lies in understanding markets in different regions and investigating market trends, this allows us to bring objective analysis along with sound advice based on our knowledge of markets and current events, this all adds up to confidence and performance.
ABRDN provides a full suite of research, trading and execution services . We have taken the time to ensure that our team can discuss any issue that you may have. If you would like to talk face to face with one of our more experienced traders, please contact us.
They are not tied to any single investment type and are not restricted by IT. That way, they can be aware of all the vital information relating to the markets as a whole. Only ABRDN has a team that is truly independent and unbiased.
Read full article at The Wall Street Journal